KIRLOSELEC

Envair Electrodyne Share Price

 

 

Start SIP in KIRLOSELEC

Start SIP

Performance

  • Low
  • ₹69
  • High
  • ₹69
  • 52 Week Low
  • ₹66
  • 52 Week High
  • ₹135
  • Open Price₹69
  • Previous Close₹72
  • Volume306
  • 50 DMA₹73.51
  • 100 DMA₹77.25
  • 200 DMA₹87.72

Investment Returns

  • Over 1 Month -4.95%
  • Over 3 Month -44.39%
  • Over 6 Month -16.68%
  • Over 1 Year -44.68%

Smart Investing Starts Here Start SIP with Envair Electrodyne for Steady Growth!

Invest Now

Envair Electrodyne Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -50
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 32
  • P/B Ratio
  • 3.8
  • Average True Range
  • 3.93
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.67
  • RSI
  • 44.89
  • MFI
  • 26.93

Envair Electrodyne Financials

Envair Electrodyne Technicals

EMA & SMA

Current Price
₹68.90
-3.42 (-4.73%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹71.55
  • 50 Day
  • ₹73.51
  • 100 Day
  • ₹77.25
  • 200 Day
  • ₹87.72

Resistance and Support

68.87 Pivot Speed
  • R3 69.32
  • R2 69.16
  • R1 69.03
  • S1 68.74
  • S2 68.58
  • S3 68.45

Envair Electrodyne Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-11 Quarterly Results
2025-05-26 Audited Results
2025-02-10 Quarterly Results
2024-11-12 Quarterly Results

Envair Electrodyne F&O

Envair Electrodyne Shareholding Pattern

No data available.

Envair Electrodyne FAQs

Envair Electrodyne share price is ₹68 As on 25 January, 2026 | 04:54

The Market Cap of Envair Electrodyne is ₹32 Cr As on 25 January, 2026 | 04:54

The P/E ratio of Envair Electrodyne is -50 As on 25 January, 2026 | 04:54

The PB ratio of Envair Electrodyne is 3.8 As on 25 January, 2026 | 04:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23